Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, resulting in a decrease in neuronal excitability.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus
* Sedation (pre-procedural or intensive care unit)
* Management of acute agitation
## Adult Dosing
* **Anxiety:** 0.5 mg to 4 mg per day, divided into 2-3 doses.
* **Insomnia:** 2 mg to 4 mg at bedtime. Generally recommended for short-term use (e.g., 7-10 days).
* **Status Epilepticus:** Intravenous (IV) or intramuscular (IM): 4 mg. Repeat in 5-15 minutes if necessary, up to a maximum of 8 mg in a 12-hour period.
* **Pre-procedural Sedation:** IV: 2 mg to 4 mg (before general anesthesia). IM: 1 mg to 4 mg (1-2 hours before surgery).
* **ICU Sedation:** IV infusion: Initial dose of 1 mg to 4 mg, followed by 0.5 mg to 4 mg per hour as needed. Titrate to desired level of sedation.
Maximum daily dose for chronic use is generally 10 mg, but higher doses may be used under strict medical supervision.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be based on age, weight, and clinical condition. Specific protocols and physician judgment are essential.
* **Status Epilepticus:** IV: 0.1 mg/kg per dose, not to exceed 4 mg per dose. May repeat doses every 5-10 minutes for a maximum of 0.4 mg/kg in 12 hours.
* **Sedation:** Dosing varies widely.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment recommended, but monitor for increased sensitivity.
* **Elderly:** Start with lower doses (e.g., half of the usual adult dose) and titrate slowly due to increased sensitivity and potential for sedation, confusion, and falls.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis (use with caution).
* Sleep apnea.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, weakness, incoordination, confusion, and fatigue. Less common effects include paradoxic reactions (e.g., excitement, aggression), amnesia, blurred vision, hypotension, and respiratory depression (especially with IV administration or in combination with other CNS depressants). Can cause physical dependence and withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **Central Nervous System (CNS) Depressants:** Alcohol, opioids, other benzodiazepines, barbiturates, sedating antihistamines, and antipsychotics can potentiate CNS depression, leading to excessive sedation, respiratory depression, coma, and death.
* **CYP450 Enzyme Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, not CYP450 enzymes, making significant interactions via this pathway less common compared to other benzodiazepines. However, drugs that inhibit glucuronidation may prolong elimination.
## Monitoring
* Level of consciousness and sedation for appropriate efficacy and safety.
* Respiratory rate, oxygen saturation, and blood pressure, especially with IV administration or in high-risk patients.
* Signs of dependence and withdrawal symptoms upon discontinuation.
* Liver and renal function periodically.
## Clinical Pearls
* Lorazepam is available in oral, sublingual, intramuscular, and intravenous formulations.
* Intravenous lorazepam can cause pain and phlebitis at the injection site. Dilution may be necessary.
* Avoid abrupt discontinuation; taper doses gradually to minimize withdrawal symptoms.
* Use in pregnancy should be carefully considered due to potential risks to the fetus.
* Be aware of the potential for abuse and diversion.
**Disclaimer:** This information is intended for healthcare professionals. Prescribing decisions should be based on the most current prescribing information available for the specific product being used and individual patient factors. Always consult the official drug monograph and relevant clinical guidelines.
